+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2020

  • PDF Icon

    Report

  • 37 Pages
  • August 2020
  • Region: Global
  • GlobalData
  • ID: 5137440
Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2020

Summary

The publisher's Medical Devices sector report, “Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Implantable Infusion Pumps pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Implantable Infusion Pumps are drug delivery system which provides continuous infusion of an agent at a constant and precise rate. The programmable infusion pump consists of an external component such as programmer and a catheter.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Implantable Infusion Pumps under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Implantable Infusion Pumps and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Implantable Infusion Pumps under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.2 List of Figures
2 Introduction
2.1 Implantable Infusion Pumps Overview
3 Products under Development
3.1 Implantable Infusion Pumps - Pipeline Products by Stage of Development
3.2 Implantable Infusion Pumps - Pipeline Products by Territory
3.3 Implantable Infusion Pumps - Pipeline Products by Regulatory Path
3.4 Implantable Infusion Pumps - Pipeline Products by Estimated Approval Date
3.5 Implantable Infusion Pumps - Ongoing Clinical Trials
4 Implantable Infusion Pumps - Pipeline Products under Development by Companies
4.1 Implantable Infusion Pumps Companies - Pipeline Products by Stage of Development
4.2 Implantable Infusion Pumps - Pipeline Products by Stage of Development
5 Implantable Infusion Pumps Companies and Product Overview
5.1 Cognos Therapeutics Inc Company Overview
5.1.1 Cognos Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Debiotech SA Company Overview
5.2.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
5.3 Eksigent Technologies LLC Company Overview
5.3.1 Eksigent Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 Eli Lilly and Co Company Overview
5.4.1 Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
5.5 Flowonix Medical Inc Company Overview
5.5.1 Flowonix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 InBrain Pharma SAS Company Overview
5.6.1 InBrain Pharma SAS Pipeline Products & Ongoing Clinical Trials Overview
5.7 Intarcia Therapeutics Inc Company Overview
5.7.1 Intarcia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Massachusetts Institute of Technology Company Overview
5.8.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
5.9 Medtronic Plc Company Overview
5.9.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.10 United Therapeutics Corp Company Overview
5.10.1 United Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.11 University of Minnesota Company Overview
5.11.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
5.12 University of Southern California Company Overview
5.12.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview
6 Implantable Infusion Pumps- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer
List of Tables
Table 1: Implantable Infusion Pumps - Pipeline Products by Stage of Development
Table 2: Implantable Infusion Pumps - Pipeline Products by Territory
Table 3: Implantable Infusion Pumps - Pipeline Products by Regulatory Path
Table 4: Implantable Infusion Pumps - Pipeline Products by Estimated Approval Date
Table 5: Implantable Infusion Pumps - Ongoing Clinical Trials
Table 6: Implantable Infusion Pumps Companies - Pipeline Products by Stage of Development
Table 7: Implantable Infusion Pumps - Pipeline Products by Stage of Development
Table 8: Cognos Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
List of Figures
Figure 1: Implantable Infusion Pumps - Pipeline Products by Stage of Development
Figure 2: Implantable Infusion Pumps - Pipeline Products by Territory
Figure 3: Implantable Infusion Pumps - Pipeline Products by Regulatory Path
Figure 4: Implantable Infusion Pumps - Pipeline Products by Estimated Approval Date
Figure 5: Implantable Infusion Pumps - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Cognos Therapeutics Inc
  • Debiotech SA
  • Eksigent Technologies LLC
  • Eli Lilly and Co
  • Flowonix Medical Inc
  • InBrain Pharma SAS
  • Intarcia Therapeutics Inc
  • Massachusetts Institute of Technology
  • Medtronic Plc
  • United Therapeutics Corp
  • University of Minnesota
  • University of Southern California